ATE391510T1 - Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii - Google Patents

Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii

Info

Publication number: ATE391510T1
Authority: AT; Austria
Prior art keywords: diabetes; treatment; type; conglutin gamma; lupin conglutin
Prior art date: 2003-02-11

Application number

AT04708771T

Other languages

English (en)

Inventor

Paolo Morazzoni

Marcello Duranti

Original Assignee

Indena Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-11

Filing date

2004-02-06

Publication date

2008-04-15

2004-02-06 Application filed by Indena Spa filed Critical Indena Spa

2008-04-15 Application granted granted Critical

2008-04-15 Publication of ATE391510T1 publication Critical patent/ATE391510T1/de

Links

241000219745 Lupinus Species 0.000 title abstract 6
208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 abstract 5
101710155000 Gamma conglutin 1 Proteins 0.000 abstract 5
239000000203 mixture Substances 0.000 abstract 2
239000003472 antidiabetic agent Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000012141 concentrate Substances 0.000 abstract 1
235000015872 dietary supplement Nutrition 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000000284 extract Substances 0.000 abstract 1
235000013305 food Nutrition 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Botany (AREA)
Diabetes (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cephalosporin Compounds (AREA)

AT04708771T 2003-02-11 2004-02-06 Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii ATE391510T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT000237A ITMI20030237A1 (it)	2003-02-11	2003-02-11	Uso della conglutina di lupino per il trattamento del

Publications (1)

Publication Number	Publication Date
ATE391510T1 true ATE391510T1 (de)	2008-04-15

Family

ID=32866063

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04708771T ATE391510T1 (de)	2003-02-11	2004-02-06	Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii

Country Status (20)

Country	Link
US (1)	US7323441B2 (de)
EP (1)	EP1605957B1 (de)
JP (2)	JP2006517212A (de)
KR (2)	KR101084434B1 (de)
CN (1)	CN1747739B (de)
AT (1)	ATE391510T1 (de)
AU (1)	AU2004212297B2 (de)
CA (1)	CA2515607C (de)
CY (1)	CY1108138T1 (de)
DE (1)	DE602004012984T2 (de)
DK (1)	DK1605957T3 (de)
ES (1)	ES2303937T3 (de)
IL (1)	IL170200A (de)
IT (1)	ITMI20030237A1 (de)
NO (1)	NO333224B1 (de)
PL (1)	PL214193B1 (de)
PT (1)	PT1605957E (de)
RU (1)	RU2339393C2 (de)
SI (1)	SI1605957T1 (de)
WO (1)	WO2004071521A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20030237A1 (it) *	2003-02-11	2004-08-12	Indena Spa	Uso della conglutina di lupino per il trattamento del
CA2726231A1 (en)	2008-05-30	2009-12-03	Fondazione Centro San Raffaele Del Monte Tabor	Uses of conglutin-y
EP2411137B1 (de)	2009-03-27	2016-09-07	Bend Research, Inc.	Sprühtrocknungsverfahren
WO2012031133A2 (en)	2010-09-03	2012-03-08	Bench Research, Inc.	Spray-drying apparatus and methods of using the same
EP2611529B1 (de)	2010-09-03	2019-01-23	Bend Research, Inc.	Sprühtrocknungsverfahren
WO2012040502A1 (en)	2010-09-24	2012-03-29	Bend Research, Inc.	High-temperature spray drying process and apparatus
AU2011315525B2 (en)	2010-10-12	2016-05-12	Consumo Em Verde - Biotecnologia Das Plantas, S.A.	Antimicrobial protein
CA2953644C (en) *	2014-06-30	2020-08-11	Prolupin Gmbh	Emulsion with lupine protein
WO2016067132A1 (en)	2014-10-31	2016-05-06	Bend Research Inc.	Process for forming active domains dispersed in a matrix

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU66892A (sh) *	1991-08-20	1995-10-24	Hoechst Ag.	Fosfoinositolglikan - peptid sa delovanjem kao insulin
JPH08127538A (ja) *	1994-10-31	1996-05-21	Masakiyo Takahashi	糖尿病治療薬
JPH0967252A (ja) *	1995-09-05	1997-03-11	Zenkoku Royal Jelly Kosei Torihiki Kiyougikai	ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤
ITMI20030237A1 (it) *	2003-02-11	2004-08-12	Indena Spa	Uso della conglutina di lupino per il trattamento del

2003
- 2003-02-11 IT IT000237A patent/ITMI20030237A1/it unknown
2004
- 2004-02-06 ES ES04708771T patent/ES2303937T3/es not_active Expired - Lifetime
- 2004-02-06 US US10/545,103 patent/US7323441B2/en not_active Expired - Lifetime
- 2004-02-06 RU RU2005125411/15A patent/RU2339393C2/ru not_active IP Right Cessation
- 2004-02-06 AT AT04708771T patent/ATE391510T1/de active
- 2004-02-06 AU AU2004212297A patent/AU2004212297B2/en not_active Ceased
- 2004-02-06 DE DE602004012984T patent/DE602004012984T2/de not_active Expired - Lifetime
- 2004-02-06 PT PT04708771T patent/PT1605957E/pt unknown
- 2004-02-06 EP EP04708771A patent/EP1605957B1/de not_active Expired - Lifetime
- 2004-02-06 CA CA2515607A patent/CA2515607C/en not_active Expired - Fee Related
- 2004-02-06 DK DK04708771T patent/DK1605957T3/da active
- 2004-02-06 PL PL377578A patent/PL214193B1/pl unknown
- 2004-02-06 SI SI200430714T patent/SI1605957T1/sl unknown
- 2004-02-06 WO PCT/EP2004/001111 patent/WO2004071521A1/en not_active Ceased
- 2004-02-06 KR KR1020057014390A patent/KR101084434B1/ko not_active Expired - Fee Related
- 2004-02-06 CN CN2004800039114A patent/CN1747739B/zh not_active Expired - Fee Related
- 2004-02-06 JP JP2006501760A patent/JP2006517212A/ja not_active Withdrawn
- 2004-02-06 KR KR1020117005984A patent/KR20110033312A/ko not_active Withdrawn
2005
- 2005-08-10 NO NO20053788A patent/NO333224B1/no not_active IP Right Cessation
- 2005-08-10 IL IL170200A patent/IL170200A/en active IP Right Grant
2008
- 2008-06-12 CY CY20081100628T patent/CY1108138T1/el unknown
2012
- 2012-04-26 JP JP2012100564A patent/JP5504301B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL170200A (en)	2010-05-31
ITMI20030237A1 (it)	2004-08-12
JP5504301B2 (ja)	2014-05-28
NO333224B1 (no)	2013-04-15
KR20110033312A (ko)	2011-03-30
KR20050106415A (ko)	2005-11-09
RU2005125411A (ru)	2006-01-27
PL377578A1 (pl)	2006-02-06
AU2004212297A1 (en)	2004-08-26
EP1605957B1 (de)	2008-04-09
CN1747739A (zh)	2006-03-15
US7323441B2 (en)	2008-01-29
PL214193B1 (pl)	2013-06-28
RU2339393C2 (ru)	2008-11-27
JP2006517212A (ja)	2006-07-20
WO2004071521A1 (en)	2004-08-26
CY1108138T1 (el)	2014-02-12
DE602004012984D1 (de)	2008-05-21
NO20053788D0 (no)	2005-08-10
US20060142185A1 (en)	2006-06-29
NO20053788L (no)	2005-11-11
PT1605957E (pt)	2008-06-27
HK1085927A1 (en)	2006-09-08
JP2012153715A (ja)	2012-08-16
AU2004212297B2 (en)	2009-09-10
CN1747739B (zh)	2013-04-17
KR101084434B1 (ko)	2011-11-21
DE602004012984T2 (de)	2009-06-04
CA2515607C (en)	2013-10-15
CA2515607A1 (en)	2004-08-26
ES2303937T3 (es)	2008-09-01
DK1605957T3 (da)	2008-08-11
SI1605957T1 (sl)	2008-08-31
EP1605957A1 (de)	2005-12-21

Legal Events

Date

Code

Title

Description

2008-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1605957

Country of ref document: EP

Publication	Publication Date	Title
CY1108138T1 (el)	2014-02-12	Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
DK1455603T3 (da)	2007-02-05	Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
MXPA05009933A (es)	2005-11-04	Composiciones que comprenden acidos grasos y aminoacidos.
BR0308799A (pt)	2007-01-09	co-glóbulos de dha e alecrim e método de uso
PL1898724T3 (pl)	2011-02-28	Preparat odżywczy dla niemowląt z hydrolizowanymi białkami
HK1049431A1 (zh)	2003-05-16	用於增加肌肉塊和力量的食物補充方法
DE60314722D1 (de)	2007-08-16	Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
BR0308713A (pt)	2005-01-04	Co-esférula de dha e alecrim, e métodos de uso
DE60333868D1 (de)	2010-09-30	Verwendung von tryptophanreichen peptiden aus molkenproteinhydrolysate zur behandlung von übergewicht und fettleibigkeit
ATE397453T1 (de)	2008-06-15	Zusammensetzung zur behandlung und/oder vorbeugung von insulinresistenz
TW200513197A (en)	2005-04-16	Amino acid supplementation for a healthy microbiota ecosystem
WO2012049430A3 (fr)	2012-07-12	Hydrolysats de proteines animales d'origine marine aux proprietes neuroprotectrices
ATE464045T1 (de)	2010-04-15	Zusammensetzung aus milchsäure und lactoferrin
BRPI0410761A (pt)	2006-06-27	uso de leucina, e, composição para administração entérica a pacientes
JP2017057147A (ja)	2017-03-23	ニンニク等、低塩分濃度の味噌、及びビタミンｂ１を含有する組成物
AR045745A1 (es)	2005-11-09	Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2
CN103478718B (zh)	2015-10-28	提高人体内谷胱甘肽浓度的功能食品及其制备方法
WO2002089741A3 (en)	2003-04-24	Compositions and methods for enhancing drug delivery
PT1581239E (pt)	2012-05-11	Utilização precoce de um extracto de folhas de videira vermelha
TW200633645A (en)	2006-10-01	Increase in the protein proportion of animal organisms
TW200733897A (en)	2007-09-16	Oral product for moistening skin
ATE405584T1 (de)	2008-09-15	Arginin/lysin-angereicherte peptide
DK1497250T3 (da)	2008-12-01	Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
DE602004030725D1 (de)	2011-02-03	Dermatologische und/oder kosmetische zusammensetzung mit polypeptiden
JP2017043593A (ja)	2017-03-02	黒ニンニク及びビタミンｂ１を含有する組成物